PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Karam Ashouri

University of Southern California

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 8, 2026 · JOURNAL ARTICLE

Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma

British Journal of Cancer

A real finding from a sound but limited study: PDLIM2 shows prognostic value in a large retrospective cohort and preclinical efficacy in mouse models, but lacks clinical trial data and the therapeutic benefit remains unvalidated in humans.

PromisingZhaoxia Qu Andrew Elliott Fan Sun

Reported

Primary/local vs metastatic PDLIM…73.1% vs 53.0%

p-value for prevalence differencep < 0.001

Median overall survival PDLIM2-hi…24.1 vs 18.1 months

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support